<< مقالات لاتين >>
<< بر اساس عنوان >>
1
Safety and efficacy of granulocyte colony-stimulating factor for patients with recent myocardial infarction: A meta-analysis
2
Safety and efficacy of heliox as a treatment for upper airway obstruction due to radiation-induced laryngeal dysfunction
3
SAFETY AND EFFICACY OF HYDERALZINE IN HYPERTENSIVE DISORDERS OF PREGNANCY
4
Safety and efficacy of hydrogen peroxide plasm sterilization for repeated use of electrophysiology catheters
5
Safety and Efficacy of Hydromorphone as an Analgesic Alternative to Morphine in Acute Pain: A Randomized Clinical Trial
6
Safety and efficacy of Hydroxychloroquine and Chloroquine in treatment of COVID-19: A rapid review of evidence
7
Safety and efficacy of hypothermic cardiopulmonary bypass and circulatory arrest for operations on the descending thoracic and thoracoabdominal aorta
8
Safety and efficacy of imatinib (STI571) in metastatic gastrointestinal stromal tumours: a phase I study
9
Safety and efficacy of implantable defibrillator therapy with programmed shock energy at twice the augmented step-down defibrillation threshold: results of the prospective, randomized, multicenter low-energy endotak trial
10
Safety and Efficacy of Inhaled Treprostinil as Add-On Therapy to Bosentan in Pulmonary Arterial Hypertension Original Research Article
11
Safety and Efficacy of Intense Antithrombotic Treatment and Percutaneous Coronary Intervention Deferral in Patients With Large Intracoronary Thrombus
12
Safety and Efficacy of Interferon β-1b in the Treatment of Severe COVID-19 Patients: An Open-Label Randomized Controlled Trial
13
Safety and efficacy of internal cardioversion of atrial fibrillation in patients with impaired left ventricular systolic function
14
Safety and efficacy of intraarterial thrombolysis for perioperative stroke after cardiac operation
15
Safety and efficacy of intracoronary stenting for thrombus-containing lesions
16
Safety and Efficacy of Intrapleural Tissue Plasminogen Activator and DNase during Extended Use in Complicated Pleural Space Infections
17
Safety and efficacy of intrathecal adjuvants for cesarean section: bupivacaine, sufentanil, or dexmedetomidine
18
Safety and efficacy of Intraurethral Mitomycin C Hydrogel for prevention of post-traumatic anterior urethral stricture recurrence after internal urethrotomy
19
Safety and efficacy of intravenous adenosine for pharmacologic stress testing in children with aortic valve disease or Kawasaki disease
20
Safety and Efficacy of Intravenous Colistin in Neonates With Culture Proven Sepsis
21
Safety and efficacy of intravenousdiltiazem in atrial fibrillation or atrial flutter
22
Safety and efficacy of intravenously administered tedisamil for rapid conversion of recent-onset atrial fibrillation or atrial flutter Original Research Article
23
Safety and Efficacy of Left Ventricular Assist Device Support in Postmyocardial Infarction Cardiogenic Shock
24
Safety and efficacy of levobupivacaine for postoperative pain relief after the surgical removal of impacted third molars: a comparison with lignocaine and adrenaline
25
Safety and efficacy of Lodoxamide in Vernal Keratoconjunctivitis
26
Safety and Efficacy of Long-Term Co-Administration of Fenofibrate and Ezetimibe in Patients With Mixed Hyperlipidemia Original Research Article
27
Safety and Efficacy of Long-Term Statin-Fibrate Combinations in Patients With Refractory Familial Combined Hyperlipidemia
28
SAFETY AND EFFICACY OF LOW ANTERIOR RESECTION WITH MESORECTAL EXCISION FOR RECTAL CANCER: A PROSPECTIVE STUDY
29
Safety and Efficacy of Low Blood Pressures Among Patients With Diabetes: Subgroup Analyses From the ONTARGET (ONgoing Telmisartan Alone and in combination with Ramipril Global Endpoint Trial)
30
Safety and Efficacy of Low-Intensity Extracorporeal Shockwave Therapy for Erectile Dysfunction: A Systematic Review and Meta-Analysis
31
Safety and Efficacy of Memantine in Improving Cognitive Function of Patients with Epilepsy
32
Safety and Efficacy of Mesotherapy in the Treatment of Androgenetic Alopecia: A Systematic Review
33
Safety and efficacy of minimally invasive atrial septal defect closure
34
Safety and efficacy of misoprostol in induction of labour in prelabour rupture of fetal membrane in Nigerian women: a multicenter study
35
Safety and efficacy of modified Jessner’s solution versus 70% glycolic acid for the treatment of melasma in different skin types: a split-face study
36
Safety and efficacy of nano lamellar TiN coatings on nitinol atrial septal defect occluders in vivo
37
Safety and Efficacy of Nebulized Racemic Epinephrine in Conjunction With Oral Dexamethasone and Mist in the Outpatient Treatment of Croup, ,
38
Safety and efficacy of off-pump coronary artery bypass grafting
39
Safety and Efficacy of Offsite Percutaneous Coronary Interventions in 1,348 Consecutive Patients in Rural Tasmania
40
Safety and efficacy of one stage off-pump coronary artery operation and carotid endarterectomy
41
Safety and efficacy of only 2 weeks of ticlopidine therapy in patients at increased risk of coronary stent thrombosis: Results from the Antiplatelet Therapy alone versus Lovenox plus Antiplatelet therapy in patients at increased risk of Stent Thrombosis (
42
Safety and Efficacy of Pacemaker Reuse in Underdeveloped Nations: A Case Series
43
Safety and efficacy of partial nephrectomy for all T1 tumors based on an international multicenter experience: Patard JJ, Shvarts O, Lam JS, Pantuck AJ, Kim HL, Ficarra V, Cindolo L, Han KR, De La Taille A, Tostain J, Artibani W, Abbou CC, Lobel B, Chopin
44
Safety and Efficacy of Paxlovid in COVID-19 Treatment: A Rapid Review
45
Safety and Efficacy of Pegylated Interferon Alfa-2a for the Treatment of Hepatitis C in Patients with Major Thalassemia
46
Safety and efficacy of percutaneous coronary interventions performed immediately after diagnostic catheterization in northern New England and comparison with similar procedures performed later
47
Safety and Efficacy of Percutaneous CT-Guided Drainage in the Management of Abdominopelvic Abscess
48
Safety and efficacy of perioperative cell salvage and autotransfusion after coronary artery bypass grafting: a randomized trial
49
Safety and Efficacy of Phenylephrine Nasal Drops in Bronchiolitis
50
Safety and Efficacy of Phototoxic Doses of Ultraviolet A for Treatment of Alopecia Areata
51
Safety and Efficacy of Pneumatic Lithotripters Versus Holmium Laser in Management of Ureteral Calculi A Randomized Clinical Trial
52
Safety and Efficacy of Pneumatic Lithotripters Versus Holmium Laser on Multiple Ureteral Calculi
53
Safety and Efficacy of Popular Iranian Herbal Cold Remedy for COVID-19: A Randomized Clinical Trial in Mild to Moderate COVID-19 Cases
54
Safety and Efficacy of Prasugrel Use in Patients Undergoing Percutaneous Coronary Intervention and Anticoagulated With Bivalirudin
55
Safety and efficacy of praziquantel syrup (Epiquantel®) against Schistosoma haematobium and Schistosoma mansoni in preschool-aged children in Niger
56
Safety and Efficacy of Preoperative Embolization in Giant Intracranial Meningiomas Compared with Resection Surgery Alone
57
Safety and efficacy of probiotic lactobacilli in promoting growth in post-weaning Swiss mice
58
Safety and Efficacy of Prosopis juliflora Leaf Extract as a Potential Treatment against Visceral Leishmaniasis in Balb/c Mice
59
Safety and Efficacy of Radiofrequency Modification of Slow Pathway Conduction in Children ≤10 Years of Age With Atrioventricular Node Reentrant Tachycardia
60
Safety and efficacy of radiotherapy treatment in elderly patients with localized prostate cancer: A retrospective analysis
61
Safety and Efficacy of Remdesivir in the Treatment of Covid-19: A Rapid Review of Available Evidence
62
Safety and efficacy of remifentanil patient-controlled analgesia versus epidural analgesia in labor
63
Safety and Efficacy of Remote Magnetic Ablation for Atrial Fibrillation
64
Safety and Efficacy of Repeated BoneMarrow Mononuclear Cell Therapy in Patients with Critical Limb Ischemia in a Pilot Randomized Controlled Trialt
65
Safety and Efficacy of RIRS in Geriatric Patients: A Comparative Evaluation on an Age Based Manner
66
Safety and Efficacy of RIRS in Geriatric Patients: A Comparative Evaluation on an Age Based Manner
67
Safety and Efficacy of Rituximab in Children with Steroid-Dependent or Resistant Nephrotic Syndrome
68
Safety and efficacy of rosuvastatin
69
Safety and efficacy of secondary prophylactic in Patients with severe hemophilia type A and B: A Systematic review and meta-analysis study
70
Safety and Efficacy of Second-Generation Everolimus-Eluting Xience V Stents Versus Zotarolimus-Eluting Resolute Stents in Real-World Practice: Patient-Related and Stent-Related Outcomes From the Multicenter Prospective EXCELLENT and RESOLUTE-Korea Registr
71
Safety and efficacy of sedation anesthesia for breast augmentation
72
Safety and Efficacy of Sertraline for Depression in Patients With Heart Failure: Results of the SADHART-CHF (Sertraline Against Depression and Heart Disease in Chronic Heart Failure) Trial
73
Safety and Efficacy of Short-Term Celecoxib Before Elective Percutaneous Coronary Intervention for Stable Angina Pectoris
74
Safety and efficacy of Sildenafil therapy in children with pulmonary hypertension
75
Safety and Efficacy of Sirolimus-Eluting Stent Implantation in Patients With Acute Coronary Syndrome in the Real World
76
SAFETY AND EFFICACY OF SITAGLIPTIN COMPARED WITH GLIMEPIRIDE IN PATIENTS WITH TYPE 2 DIABETES MELLITUS INADEQUATELY CONTROLLED WITH METFORMIN MONOTHERAPY
77
Safety and efficacy of sodium caprate in promoting oral drug absorption: from in vitro to the clinic
78
Safety and efficacy of sorafenib in patients with castrate resistant prostate cancer: A Phase II study
79
Safety and Efficacy of Statins in Asians
80
Safety and Efficacy of Subcutaneous-Only Granulocyte-Macrophage Colony-Stimulating Factor for Collateral Growth Promotion in Patients With Coronary Artery Disease Original Research Article
81
Safety and efficacy of superselective angioembolization in control of lower gastrointestinal hemorrhage
82
Safety and Efficacy of Switching From Either Unfractionated Heparin or Enoxaparin to Bivalirudin in Patients With Non–ST-Segment Elevation Acute Coronary Syndromes Managed With an Invasive Strategy: Results From the ACUITY (Acute Catheterization and Urgen
83
Safety and efficacy of terbinafine in a pediatric Iranian cohort of patients with Tinea capitis
84
Safety and efficacy of terbinafine in a pediatric Iranian cohort of patients with Tinea capitis
85
Safety and Efficacy of the 2.25-mm Sirolimus-Eluting Bx Velocity Stent in the Treatment of Patients With De Novo Native Coronary Artery Lesions: the SIRIUS 2.25 Trial
86
Safety and efficacy of the CYPHER Select Sirolimus-eluting stent in the “Real World”—Clinical and angiographic results from the China CYPHER Select registry
87
Safety and Efficacy of the FilterWire EZ in Acute ST-Segment Elevation Myocardial Infarction
88
Safety and efficacy of the HIV-1 integrase inhibitor raltegravir (MK-0518) in treatment-experienced patients with multidrug-resistant virus: a phase II randomised controlled trial
89
Safety and Efficacy of the Noncessation Method of Antithrombotic Agents after Emergency Endoscopic Hemostasis in Patients with Nonvariceal Upper Gastrointestinal Bleeding: A Multicenter Pilot Study
90
Safety and efficacy of the Percutaneous Nephrolithotomy in Pediatrics; A 10-year single-center experience in Iran
91
Safety and efficacy of the POP technique for restoring patency to occluded PIC catheters
92
Safety and Efficacy of the StarClose Vascular Closure System following 8-Fr Sheath Placement for Intra-Aortic Balloon Pump: A Single-Center Analysis of 42 Consecutive Patients
93
Safety and efficacy of the supraclavicular approach to thoracic outlet decompression
94
Safety and efficacy of the supracostal access for percutaneousnephrolithotomy: Our initial experience
95
Safety and Efficacy of the XIENCE V Everolimus-Eluting Stent Compared to First-Generation Drug-Eluting Stents in Contemporary Clinical Practice
96
Safety and Efficacy of Tomotherapy for Lung Cancer Compared to Other Radiotherapy Techniques: A Systematic Review
97
Safety and efficacy of total thyroidectomy in hands of endocrine surgery trainees
98
Safety and Efficacy of Transcatheter Arterial Chemoemboliazation in the Real-Life Management of Unresectable Hepatocellular Carcinoma
99
Safety and efficacy of transfusions of autologous cryopreserved platelets derived from recombinant human thrombopoietin to support chemotherapy-associated severe thrombocytopenia: a randomised cross-over study
100
Safety and Efficacy of Transition from Systemic Prostanoids to Inhaled Treprostinil in Pulmonary Arterial Hypertension
101
Safety and efficacy of transurethral pneumatic lithotripsy for bladder calculi in children
102
Safety and Efficacy of Triple Therapeutic Targets with Rivaroxaban after Acute Myocardial Infarction Complicated by Left Ventricular Thrombi in a Case of Nonvalvular Atrial Fibrillation
103
SAFETY an‎d EFFICACY OF TUBELESS PERCUTANEOUS NEPHROLITHOTOMY
104
Safety and Efficacy of Two Different Doses of Everolimus in Kidney Transplantation A Systematic Review and Meta-Analysis
105
Safety and Efficacy of Two Drugs, Ondansetreon and Meperidine, in Preventing Shivering after Anesthesia in Orthopedic Surgery Candidates: A Systematic Review Study
106
Safety and Efficacy of Ultrasound-Guided Combined Segmental Thoracic Spinal Epidural Anesthesia in Abdominal Surgeries and Laparoscopic Procedures: A Prospective Randomized Clinical Study
107
Safety and efficacy of unfractionated heparin versus enoxaparin in patients who are obese and patients with severe renal impairment: analysis from the ESSENCE and TIMI 11B studies
108
Safety and efficacy of using the stone cone and an entrapment and extraction device in ureteroscopic lithotripsy for ureteric stones
109
Safety and efficacy of vaccination against streptococcus pneumonia in patients with rheumatic diseases
110
Safety and efficacy of Vagus Nerve Stimulation in treatment-resistant depression. A systematic review
111
Safety and efficacy of valsartan versus enalapril in heart failure patients
112
Safety and efficacy of venom immunotherapy: a real life study
113
Safety and efficacy of vigabatrin and carbamazepine
114
Safety and efficacy of vigabatrin and carbamazepine
115
Safety and efficacy of vigabatrin and carbamazepine in ne wly diagnosed epilepsy: a multicentre randomised double-blind study Original Research Article
116
Safety and efficacy of whole breast irradiation with a concomitant boost. Analysis of 121 cases treated at the Alexis-Vautrin Cancer Center
117
Safety and efficacy of whole breast irradiation with a concomitant boost. Analysis of 121 cases treated at the Alexis-Vautrin Cancer Center
118
Safety and efficacy of zinc supplementation for children with HIV-1 infection in South Africa: a randomised double-blind placebo-controlled trial
119
Safety and efficacy of Zingiber officinale roots on fertility of male diabetic rats
120
Safety and Efficacy Outcomes of Overlapping Second-Generation Everolimus-Eluting Stents Versus First-Generation Drug-Eluting Stents
121
Safety and efficacy studies on trivalent inactivated vaccines against infectious coryza
122
Safety and efficacy studies on trivalent inactivated vaccines against infectious coryza
123
Safety and Efficiency of Pyeloplasty in The First Six Weeks of Infants Life
124
Safety and Efficiency of Pyeloplasty in The First Six Weeks of Infants Life
125
Safety and environment aspects of a fusion power reactor
126
Safety and environmental risk assessment of the mountain sport and resorts of Tehran with an emphasis on the sustainable tourism carrying capacity and the provision of management approaches
127
Safety and Environmental Sustainability of Strategic Gasoil Tanks, Affected by Fire and Explosion Incidents in the Oil Facilities of Southern Ahvaz
128
Safety and ergonomics evaluation of hybrid systems in Hong Kong
129
Safety and feasibility of a clinical pathway for the outpatient initiation of antiarrhythmic medications in patients with atrial fibrillation or atrial flutter
130
Safety and feasibility of a novel rate-smoothed ventricular pacing algorithm for atrial fibrillation
131
Safety and Feasibility of an Intravascular Optical Coherence Tomography Image Wire System in the Clinical Setting
132
Safety and feasibility of continuous monitoring of coronary flow velocity in acute myocardial infarction by Doppler guide wire
133
Safety and feasibility of dobutamine stress echocardiography in patients with implantable cardioverter defibrillators
134
Safety and Feasibility of Elective High-Risk Percutaneous Coronary Intervention Procedures With Left Ventricular Support of the Impella Recover LP 2.5
135
Safety and feasibility of image-guided robotic radiosurgery for patients with limited bone metastases of prostate cancer
136
Safety and feasibility of image-guided robotic radiosurgery for patients with limited bone metastases of prostate cancer
137
Safety and feasibility of intravenous thrombolytic therapy in Iranian patients with acute ischemic stroke
138
Safety and Feasibility of Outpatient High Dose Cytarabine for Acute Myeloid Leukemia in the Brazilian Amazon
139
Safety and feasibility of radiotherapy treatment in elderly non-small-cell lung cancer (NSCLC) patients
140
Safety and Feasibility of Robotic Percutaneous Coronary Intervention: PRECISE (Percutaneous Robotically-Enhanced Coronary Intervention) Study
141
Safety and Feasibility of Same Day Discharge in Patients Undergoing Radiofrequency Catheter Ablation
142
Safety and Feasibility of Transendocardial Autologous Bone Marrow Cell Transplantation in Patients With Advanced Heart Disease
143
Safety and feasibility of using serial infusions of nesiritide for heart failure in an outpatient setting (from the FUSION I trial)
144
Safety and feasibility trial of the MicroMed DeBakey ventricular assist device as a bridge to transplantation
145
Safety and fetal outcome of early and midtrimester amniocentesis
146
Safety and fetal outcome of early and midtrimester amniocentesis
147
Safety and fetal outcome of early and midtrimester amniocentesis
148
Safety and fetal outcome of early and midtrimester amniocentesis
149
Safety and functional aspects of pre-selected lactobacilli for probiotic use in Iberian dry-fermented sausages
150
SAFETY AND HAZARDS OF MATERIALS USED IN THE FABRICATION OF DENTAL PROSTHESES
151
Safety and healing efficacy of Sea buckthorn (Hippophae rhamnoides L.) seed oil on burn wounds in rats
152
Safety and health educational needs of agricultural education and industry professionals
153
Safety and Health Management System, Safety Climate, and Accident Occurrences in Hospitals: The Study of Needlestick, Sharp Injuries and Recidivism Rates
154
Safety and Health Protection of Health Care Workers during the COVID19 Pandemic
155
Safety and Health Risk Assessment in Mosques, Shiraz, Iran
156
Safety and Hemodynamic Effects of Intravenous Triiodothyronine in Advanced Congestive Heart Failure
157
Safety and hemostatic effect of recombinant activated factor VII in cirrhotic patients undergoing partial hepatectomy: a multicenter, randomized, double-blind, placebo-controlled trial
158
Safety and Immune Responses to Attenuated Salmonella enterica Serovar Typhi Oral Live Vector Vaccines Expressing Tetanus Toxin Fragment C
159
SAFETY AND IMMUNOGENICITY OF A NEW EQUINE TETANUS IMMUNOGLOBULIN ASSOCIATED WITH TETANUS-DIPHTHERIA VACCINE
160
Safety and immunogenicity of a Vero-cell-derived, inactivated Japanese encephalitis vaccine: a non-inferiority, phase III, randomised controlled trial
161
Safety and immunogenicity of an inactivated adjuvanted whole-virion influenza A (H5N1) vaccine: a phase I randomised controlled trial
162
Safety and immunogenicity of an inactivated split-virion influenza A/Vietnam/1194/2004 (H5N1) vaccine: phase I randomised trial
163
Safety and immunogenicity of an oral DNA vaccine encoding Sip of Streptococcus agalactiae from Nile tilapia Oreochromis niloticus delivered by live attenuated Salmonella typhimurium
164
Safety and immunogenicity of H5N1 vaccine
165
Safety and Immunogenicity of Hepatitis B Vaccine: a Study on Iranian Navy Personnel
166
Safety and immunogenicity of new cell-cultured smallpox vaccine compared with calf-lymph derived vaccine: a blind, single-centre, randomised controlled trial
167
Safety and In-Hospital Outcomes of Bivalirudin Use in Dialysis Patients Undergoing Percutaneous Coronary Intervention
168
Safety and intestinal microbiota modulation by the exopolysaccharide-producing strains Bifidobacterium animalis IPLA R1 and Bifidobacterium longum IPLA E44 orally administered to Wistar rats
169
Safety and long-term efficacy of revisional surgery in severe obesity
170
Safety and low molecular weight heparin in older people in a hospital with ambulatory care
171
Safety and mechanisms of intracoronary manual stepping brachytherapy as gained from serial angiographic and intravascular ultrasound studies
172
Safety and mutagenicity evaluation of red mold dioscorea fermented from Monascus purpureus NTU 568
173
Safety and optimal dose of intracoronary adenosine 5ʹ-triphosphate for the measurement of coronary flow reserve, ,
174
Safety and Performance Characteristics of Outpatient Medical Thoracoscopy and Indwelling Pleural Catheter Insertion for Evaluation and Diagnosis of Pleural Disease at a Tertiary Center in Canada
175
Safety and Pharmacokinetic Profile of Gadobenate Dimeglumine in Subjects With Renal Impairment
176
Safety and potential risks of enterococci isolated from traditional fermented capers
177
Safety and practicality of magnetic resonance imaging (MRI) for non-invasive assessment of coronary stents
178
Safety and quality issues in fish processing: Editor: H. Allan Bremmer. CRC Press, Woodhead Publishing, Cambridge, England, 2002; xvii+507 pages, hardback, Woodhead Publishing ISBN 1 85573 552 0; UK£150.00/US$235.00/€235.00+P&P. E-mail ; Web page:
179
Safety and quality issues in fish processing: Editor: H. Allan Bremmer. CRC Press, Woodhead Publishing, Cambridge, England, 2002; xvii+507 pages, hardback, Woodhead Publishing ISBN 1 85573 552 0; UK£150.00/US$235.00/€235.00+P&P. E-mail ; Web page:
180
Safety and Quality of Beef Meat Sausages Produced in the Industrial Factory Using the HACCP System
181
Safety and Quality of Farm Fresh Goat’s Cheese in the Czech Republic
182
Safety and quality of ready-to-eat dry fermented sausages subjected to E-beam radiation
183
Safety and quality of some chicken meat products in Al-Ahsa markets-Saudi Arabia
184
Safety and radiation-enhancing effect of sodium glycididazole in locoregionally advanced laryngeal cancers previously treated with platinum-containing chemotherapy regimens: A preliminary report
185
Safety and reliability considerations for lithium batteries
186
Safety and reliability for managing risk
187
Safety and reliability for managing risk
188
Safety and reliability in industrial management
189
Safety and reliability of comma-free digital coding for railway track circuits
190
Safety and Reliability: ESRELʹ99: G.I. Schueller, P. Kafka (Eds.)
191
Safety and reproductive safety of moxidectin in goats
192
Safety and Results of Cryoablation in Patients <5 Years Old and/or <15 Kilograms
193
Safety and results of dobutamine stress echocardiography in women versus men and in patients older and younger than 75 years of age
194
Safety and risk assessment of the genetically modified Lactococci on rats intestinal bacterial flora
195
Safety and Risk/Benefit Analysis of Ibutilide for Acute Conversion of Atrial Fibrillation/Flutter
196
Safety and security concerns in tourism industry: A conceptual review
197
Safety and Security in Tourism: Relationships, Management and Marketing
198
Safety and security target levels: Opportunities and challenges for risk management and risk communication
199
Safety and storage stability of horse meat for human consumption
200
Safety and technical success of methylene blue dye for lymphatic mapping in breast cancer
201
Safety and technical success of percutaneous left main coronary artery stenting
202
Safety and technological characterization of Staphylococcus equorum isolates from jeotgal, a Korean high-salt-fermented seafood, for starter development
203
Safety and the car size effect: A fundamental explanation
204
Safety and Therapeutic Effects of Repetitive Transcranial Magnetic Stimulation and Behavior Therapy in a Pregnant Woman: Case Report
205
Safety and tolerability of abciximab in patients with acute miocardial infarction and failed thrombolysis
206
Safety and tolerability of bosentan in adults with Eisenmenger physiology
207
Safety and Tolerability of Dalcetrapib
208
Safety and tolerability of gamma-hydroxybutyric acid in the treatment of alcohol-dependent patients
209
Safety and tolerability of gene therapy with an adeno-associated virus (AAV) borne GAD gene for Parkinsonʹs disease: an open label, phase I trial
210
Safety and tolerability of higher-dose intravenous bisphosphonates in metastatic breast cancer
211
Safety and tolerability of intraputaminal delivery of CERE-120 (adeno-associated virus serotype 2–neurturin) to patients with idiopathic Parkinsonʹs disease: an open-label, phase I trial
212
Safety and tolerability of intravenous cibenzoline for acute termination of spontaneous sustained ventricular tachycardia: Cibenzoline and spontaneous VT
213
Safety and tolerability of intravenous-to-oral treatment and single-dose intravenous or oral prophylaxis with trovafloxacin
214
Safety and Tolerability of Long-term Propafenone Therapy for Supraventricular Tachyarrhythmias
215
Safety and tolerability of Miltuximab® - a first in human study in patients with advanced solid cancers
216
Safety and tolerability of oxcarbazepine in elderly patients with epilepsy
217
Safety and tolerability of repetitive transcranial magnetic stimulation in patients with epilepsy: a review of the literature
218
Safety and Tolerability of Serial Home Infusions of Nesiritide for Advanced Heart Failure
219
Safety and tolerability of simvastatin plus niacin in patients with coronary artery disease and low high-density lipoprotein cholesterol (The HDL Atherosclerosis Treatment Study)
220
Safety and tolerance of Lactobacillus reuteri supplementation to a population infected with the human immunodeficiency virus
221
Safety and Toxicological Evaluation of Ferrocenium Tetrachloroantimonate for Use as an Antimalarial Agent
222
Safety and transcervical endometrial resection
223
Safety and usability evaluation of a web-based insulin self-titration system for patients with type 2 diabetes mellitus
224
Safety and usefulness of autologous cryopreserved platelets
225
Safety and usefulness of autologous cryopreserved platelets
226
Safety and usefulness of autologous cryopreserved platelets
227
Safety and utility of computer-aided shoulder arthroplasty
228
Safety approach for composite pressure vessels for road transport of hydrogen. Part 1: Acceptable probability of failure and hydrogen mass
229
Safety approach for composite pressure vessels for road transport of hydrogen. Part 2: Safety factors and test requirements
230
Safety approach for plasma anomaly events in fusion reactor: Code development and assessments
231
Safety approach in the EU test blanket systems design
232
Safety as perceived by wheelchair-seated passengers in special transportation services
233
Safety aspect of long-life small safe power reactors
234
Safety aspects of a bubbly medium inside a chemical reactor
235
Safety aspects of chronic low-frequency transcranial magnetic stimulation based on localized proton magnetic resonance spectroscopy and histology of the rat brain
236
Safety aspects of enterococci from the medical point of view
237
Safety aspects of freeway weaving sections
238
Safety aspects of future infrastructure scenarios with hydrogen refuelling stations
239
Safety aspects of gadofosveset in clinical practice – analysis of acute and long-term complications
240
Safety aspects of GSM systems on high-voltage towers: an experimental analysis
241
Safety aspects of joints and coatings for plasma facing components with composite structures
242
Safety Aspects of Local Tropical Food Production: Essential Oil Incorporation as a Safe Approach
243
Safety aspects of oxide fuels for transmutation and utilization in accelerator driven systems
244
SAFETY ASPECTS OF RESEARCH REACTOR CORE FUEL CONVERSION FROM HIGHLY ENRICHED URANIUM TO LOW ENRICHED URANIUM
245
Safety aspects regarding the consumption of high-dose dietary diacylglycerol oil in men and women in a double-blind controlled trial in comparison with consumption of a triacylglycerol control oil
246
Safety aspects, genetic diversity and technological characterisation of wild-type Streptococcus thermophilus strains isolated from north Italian traditional cheeses
247
Safety assessment and evaluation of probiotic potential of bacteriocinogenic Enterococcus faecium KH 24 strain under in vitro and in vivo conditions
248
Safety assessment and the software requirements specification
249
Safety assessment approach of hazard and operability (HAZOP) for sulfur recovery unit Claus reaction furnace package; blower; heat exchanger equipment in South Pars gas processing plant
250
Safety Assessment Based on Irrelevant Toxicologic Data: An Extraordinary Case of Bromomethane Used as a Fumigant
251
Safety assessment considerations for food and feed derived from plants with genetic modifications that modulate endogenous gene expression and pathways
252
Safety assessment for ITER-FEAT tritium systems
253
Safety assessment in the built environment of Saudi Arabia
254
Safety assessment of (−)-hydroxycitric acid and Super CitriMax®, a novel calcium/potassium salt
255
Safety assessment of 2-ethyl-3,(5 or 6) dimethylpyrazine as a food ingredient
256
Safety assessment of a modified acetolactate synthase protein (GM-HRA) used as a selectable marker in genetically modified soybeans
257
Safety assessment of a new multivitamin
258
Safety Assessment of a New Strain of Lactobacillus pentosus (IBRC=11143) as a Candidate Probiotic
259
Safety assessment of a novel ingredient for removable chewing gum
260
Safety assessment of a proprietary preparation of a novel Probiotic, Bacillus coagulans, as a food ingredient
261
Safety assessment of a short span railway bridge for high-speed traffic using simulation techniques
262
Safety assessment of a solid lipid curcumin particle preparation: Acute and subchronic toxicity studies
263
Safety assessment of A92 reactor building for large commercial aircraft crash
264
Safety assessment of AC earthing systems in a DC traction-supply substation
265
Safety assessment of AGPC as a food ingredient
266
Safety assessment of alicyclic flavourings
267
Safety assessment of allergic contact dermatitis hazards: An analysis supporting reduced animal use for the murine local lymph node assay
268
Safety assessment of allylalkoxybenzene derivatives used as flavouring substances — methyl eugenol and estragole
269
Safety assessment of anticoagulation therapy in patients with hemorrhagic cerebral venous thrombosis.
270
Safety assessment of Apoaequorin, a protein preparation: Subchronic toxicity study in rats
271
Safety assessment of aqueous olive pulp extract as an antioxidant or antimicrobial agent in foods
272
Safety Assessment of Arctium lappa L. Fruit Extract in Female Wistar Rats: Acute and Repeated Oral Toxicity Studies
273
Safety assessment of astaxanthin-rich microalgae biomass: Acute and subchronic toxicity studies in rats
274
Safety assessment of biotechnology used in animal production, including genetically modified (GM) feed and GM animals – a review
275
Safety assessment of black cumin fixed and essential oil in normal Sprague dawley rats: Serological and hematological indices
276
Safety assessment of boron by application of new uncertainty factors and their subdivision
277
Safety Assessment of Bulk and Traction Supply Substations in Taipei Rail Transit Systems
278
Safety Assessment of Butylated Hydroxyanisole and Butylated Hydroxytoluene as Antioxidant Food Additives
279
Safety assessment of Cissus quadrangularis extract (CQR-300): Subchronic toxicity and mutagenicity studies
280
Safety assessment of coenzyme Q10 (Kaneka Q10) in healthy subjects: A double-blind, randomized, placebo-controlled trial
281
Safety Assessment of Concrete Tunnel Linings under Fire Load
282
Safety assessment of consumption of glabrous canary seed (Phalaris canariensis L.) in rats
283
Safety assessment of Cordyceps guangdongensis
284
Safety assessment of coriander (Coriandrum sativum L.) essential oil as a food ingredient
285
Safety assessment of Cry1Ab/Ac fusion protein
286
Safety assessment of Cry1C protein from genetically modified rice according to the national standards of PR China for a new food resource
287
Safety assessment of dairy microorganisms: Aerobic coryneform bacteria isolated from the surface of smear-ripened cheeses
288
Safety assessment of dairy microorganisms: Bacterial taxonomy
289
Safety assessment of dairy microorganisms: Coagulase-negative staphylococci
290
Safety assessment of dairy microorganisms: Geotrichum candidum
291
Safety assessment of dairy microorganisms: Propionibacterium and Bifidobacterium
292
Safety assessment of dairy microorganisms: Streptococcus thermophilus
293
Safety assessment of dairy microorganisms: The Enterococcus genus
294
Safety assessment of dairy microorganisms: The hemiascomycetous yeasts
295
Safety assessment of dairy microorganisms: The Lactobacillus genus
296
Safety assessment of dairy microorganisms: The Lactococcus genus
297
Safety assessment of dairy microorganisms: The Leuconostoc genus
298
Safety assessment of dams by analysis of the electrical properties of the embankment material
299
Safety assessment of dehydration-responsive element-binding (DREB) 4 protein expressed in E. coli
300
Safety assessment of DHA-rich microalgae from Schizochytrium sp. Part V: target animal safety/toxicity study in growing swine
301
Safety Assessment of DHA-Rich Microalgae from Schizochytrium sp.: I. Subchronic Rat Feeding Study
302
Safety Assessment of DHA-Rich Microalgae from Schizochytrium sp.: II. Developmental Toxicity Evaluation in Rats and Rabbits
303
Safety Assessment of DHA-Rich Microalgae from Schizochytrium sp.: III. Single-Generation Rat Reproduction Study
304
Safety Assessment of DHA-Rich Microalgae from Schizochytrium sp.: IV. Mutagenicity Studies
305
Safety assessment of diacylglycerol oil as an edible oil: A review of the published literature
306
Safety assessment of dietary administered paprika color in combined chronic toxicity and carcinogenicity studies using F344 rats
307
Safety assessment of dietary bamboo charcoal powder: A 90-day subchronic oral toxicity and mutagenicity studies
308
Safety assessment of dietary diacylglycerol oil: A two-generation reproductive toxicity study in rats
309
Safety assessment of ellagic acid, a food additive, in a subchronic toxicity study using F344 rats
310
Safety assessment of energy fluxes on in-vessel components with SAFALY
311
Safety assessment of envisaged systems for automotive hydrogen supply and utilization
312
Safety assessment of EPA-rich oil produced from yeast: Results of a 90-day subchronic toxicity study
313
Safety assessment of EPA-rich triglyceride oil produced from yeast: Genotoxicity and 28-day oral toxicity in rats
314
Safety assessment of esters of p-hydroxybenzoic acid (parabens)
315
Safety assessment of food and feed from biotechnology-derived crops employing RNA-mediated gene regulation to achieve desired traits: A scientific review
316
Safety assessment of gamma-glutamylcysteine sodium salt
317
Safety assessment of genetically modified rice expressing human serum albumin from urine metabonomics and fecal bacterial profile
318
Safety assessment of glycol recovery unit in a gas refinery by failure mode and effects analysis technique
319
Safety assessment of greenhouse hydroponic tomatoes irrigated with reclaimed and surface water
320
Safety assessment of heated diacylglycerol oil: Subchronic toxicity study in rats
321
Safety assessment of heat-sterilized green tea catechin preparation: A 6-month repeat-dose study in rats
322
Safety assessment of hydroxypropyl methylcellulose as a food ingredient
323
Safety assessment of iron EDTA [sodium iron (Fe3+) ethylenediaminetetraacetic acid]: summary of toxicological, fortification and exposure data
324
Safety assessment of kola nut extract as a food ingredient
325
Safety assessment of Lactobacillus brevis KB290 as a probiotic strain
326
Safety Assessment of Lactobacillus paracasei IBRC-M 11110 in Wistar rats: a subacute 28-day toxicity study
327
Safety assessment of Lactobacillus plantarum JDM1 based on the complete genome
328
Safety assessment of Lactobacillus strains: Presence of putative risk factors in faecal, blood and probiotic isolates
329
Safety assessment of lutein and zeaxanthin (Lutemax™ 2020): Subchronic toxicity and mutagenicity studies
330
Safety assessment of meat from transgenic cattle by 90-day feeding study in rats
331
Safety assessment of melinjo (Gnetum gnemon L.) seed extract: Acute and subchronic toxicity studies
332
Safety Assessment of Mentha mozaffarianii Essential Oil: Acute and Repeated Toxicity Studies
333
Safety assessment of methanol extract of red dragon fruit (Hylocereus polyrhizus): Acute and subchronic toxicity studies
334
Safety assessment of mushroom β-glucan: Subchronic toxicity in rodents and mutagenicity studies
335
Safety assessment of myristic acid as a food ingredient
336
Safety assessment of N-acetyl-l-threonine
337
Safety Assessment of Neoadjuvant Pertuzumab Combined with Trastuzumab in Nonmetastatic HER2-Positive Breast Cancer in Postmenopausal Elderly Women of South Asia
338
Safety Assessment of Ocimum Basilicum Hydroalcoholic Extract in Wistar Rats: Acute and Subchronic Toxicity Studies
339
Safety assessment of offshore structure
340
Safety Assessment of Osthole Isolated from Prangos ferulacea: Acute and Subchronic Toxicities and Modulation of Cytochrome P450
341
safety assessment of osthole isolated from prangos ferulacea: acute and subchronic toxicities and modulation of cytochrome p450
342
Safety assessment of people in public building fire incidents using harmony search algorithm
343
Safety assessment of perflenapent emulsion for echocardiographic contrast enhancement in patients with congestive heart failure or chronic obstructive pulmonary disease
344
Safety assessment of pipes with multiple local wall thinning defects under pressure and bending moment
345
Safety assessment of polylactide (PLA) for use as a food-contact polymer
346
Safety assessment of pomegranate fruit extract: Acute and subchronic toxicity studies
347
Safety assessment of potential probiotic lactic acid bacterial strains Lactobacillus rhamnosus HN001, Lb. acidophilus HN017, and Bifidobacterium lactis HN019 in BALB/c mice
348
Safety assessment of propyl paraben: a review of the published literature
349
Safety assessment of rice bran oil in a chicken embryo model
350
Safety assessment of sandalwood oil (Santalum album L.)
351
Safety assessment of SDA soybean oil: Results of a 28-day gavage study and a 90-day/one generation reproduction feeding study in rats
352
Safety assessment of single-bolus administration of TNK tissue-plasminogen activator in acute myocardial infarction: The ASSENT-1 trial, , ,
353
Safety assessment of smoked fish related to Listeria monocytogenes prevalence using risk management metrics
354
Safety assessment of steel-plate girder bridges subjected to military load classification
355
Safety assessment of structures in view of fuzzy randomness
356
Safety assessment of Syzygium aromaticum flower bud (clove) extract with respect to testicular function in mice
357
Safety assessment of the butyrate-producing Butyricicoccus pullicaecorum strain 25-3T, a potential probiotic for patients with inflammatory bowel disease, based on oral toxicity tests and whole genome sequencing
358
Safety assessment of the commensal strain Bacteroides xylanisolvens DSM 23964
359
Safety assessment of the fermented Phylloporia ribis (Lonicera japonica Thunb.) mycelia by oral acute toxicity study in mice and 90-day feeding study in rats
360
Safety assessment of the lithium target of the international fusion materials irradiation facility
361
Safety assessment of the post-harvest treatment of button mushrooms (Agaricus bisporus) using ultraviolet light
362
Safety assessment of the Quercus brantii gall hydroalcoholic extract: Single and repeated oral dose toxicity studies
363
Safety assessment of transgenic Bacillus thuringiensis with VIP insecticidal protein gene by feeding studies
364
Safety assessment of two advanced ferritic steel molten salt blanket design concepts
365
Safety assessment of unignited hydrogen discharge from onboard storage in garages with low levels of natural ventilation
366
Safety assessment of yerba mate (Ilex paraguariensis) dried extract: Results of acute and 90 days subchronic toxicity studies in rats and rabbits
367
Safety assessment of Ylang–Ylang (Cananga spp.) as a food ingredient
368
Safety Assessment of Zanjan Drinking Water System Using Water Safety Plan
369
Safety assessment of Zanthoxylum alatum Roxb. essential oil, its antifungal, antiaflatoxin, antioxidant activity and efficacy as antimicrobial in preservation of Piper nigrum L. fruits
370
Safety assessment of β-nitropropionic acid: a monograph in support of an acceptable daily intake in humans
371
Safety assessment of γ-cyclodextrin
372
Safety assurance via on-line monitoring
373
Safety at sea and fisheries management:: fishermenʹs attitudes and the need for co-management
374
Safety at the Racetrack: Results of Restrictor Plates in Superspeedway Competition
375
Safety Attitude and Its Associated Factors among Workers in Micro- and Small-Scale Enterprises (MSSEs) in Shiraz
376
Safety Attitude and Its Predictor Individual and Organizational Variables among Nurses: A Cross-Sectional Study
377
Safety Attitudes among Nurses and Its Relation with Occupational Accidents: A Questionnaire Based Survey
378
Safety Based Cross Sectional Study of Infrastructure and Associated Problems among Undeveloped Neighborhoods
379
Safety becomes danger: dilemmas of drug-use in public space
380
Safety behaviors and dysfunctional beliefs about sleep: Testing a cognitive model of the maintenance of insomnia
381
Safety behaviors and sleep effort predict sleep disturbance and fatigue in an outpatient sample with anxiety and depressive disorders
382
Safety behaviour does not necessarily interfere with exposure therapy
383
Safety behaviour: A reconsideration
384
Safety beliefs and safe behavior among midwestern college students
385
Safety belt nonuse by internal medicine patients: A missed opportunity in clinical preventive medicine
386
Safety by design: An engineerʹs responsibility for safety : Edited by Sue Cox, Published by the Hazards Forum, London, 1996, 149 pages, ISBN 0952 5103-1-6
387
Safety by Uninterpreted Locks
388
Safety certification of airborne software: An empirical study
389
Safety certification of airborne software: An empirical study
390
Safety Challenges in Psychiatric Departments from Nurses’ Perspective: A Qualitative Study
391
Safety characteristics of lithium alloy/metal sulfide batteries
392
Safety characteristics of rechargeable lithium metal cells
393
Safety characteristics of the multipurpose fast reactor (MPFR)
394
Safety checking in an automatic train operation system
395
Safety classification of the ITER fusion power shutdown system and resulting safety requirements
396
Safety climate
397
Safety climate and attitude as evaluation measures of organizational safety
398
Safety climate and safety performance among construction workers in Hong Kong: The role of psychological strains as mediators
399
Safety climate and self-reported injury: Assessing the mediating role of employee safety control
400
Safety climate differences among job positions in a nuclear decommissioning and demolition industry: Employees’ self-reported safety attitudes and perceptions
401
Safety climate factors, group differences and safety behaviour in road construction
402
Safety climate in university and college laboratories: Impact of organizational and individual factors
403
Safety climate, attitudes and risk perception in Norsk Hydro
404
Safety climate, nursing organizational culture and the intention to report medication errors: A cross-sectional study of hospital nurses
405
Safety climate, safety management practice and safety performance in offshore environments
406
Safety communications: Warnings
407
Safety concept for hazards caused by ice avalanches from the Whymper hanging glacier in the Mont Blanc Massif
408
Safety concept of the IFMIF/EVEDA lithium test loop
409
Safety concerns about digoxin after acute myocardial infarction Original Research Article
410
Safety concerns about kava
411
Safety concerns about kava not unique
412
Safety concerns in ultrahigh pressure capillary liquid chromatography using air-driven pumps
413
Safety concerns over antipsychotic drug, sertindole
414
Safety concerns to application of graphene compounds in pharmacy and medicine
415
Safety conditions in manholes in the vicinity of substations
416
Safety conscious planning in small and medium-sized MPOs and rural planning agencies: Results of a domestic scan
417
Safety consciousness: Assignments that expand focus beyond the bedside
418
SAFETY CONSIDERATIONS FOR CORE MANAGEMENT AND FUEL HANDLING FOR RESEARCH REACTORS
419
Safety considerations for operating room personnel during hyperthermic intraoperative intraperitoneal chemotherapy perfusion
420
Safety considerations for the aging workforce
421
Safety considerations in large-volume lipoplasty
422
Safety considerations in the pharmacological management of atrial fibrillation
423
Safety considerations of aerial systems using insulated and covered wire and cable
424
Safety Considerations of Laparoscopic Surgeries for Anesthesiologists During COVID-19 Pandemic?
425
Safety Considerations on MRI Systems for Firefighters and Paramedics
426
Safety considerations when placing a person with tools in an air gap to change porcelain and glass insulators on transmission systems of 345 kV and above, using ladder and aerial lift methods
427
Safety constraints applied to an adaptive Bayesian condition-based maintenance optimization model
428
Safety constraints applied to an adaptive Bayesian condition-based maintenance optimization model
429
Safety Controversies in Tooth Bleaching
430
Safety cost of a large scale hydrogen system for photovoltaic energy regulation
431
Safety criteria and quality control of HTTR fuel
432
Safety criteria and quality control of HTTR fuel Original Research Article
433
Safety Cultural Assessment among Management, Supervisory and Worker Groups in a Tar Refinery Plant
434
Safety culture and accident risk control: Perceptions of professional divers and offshore workers
435
Safety culture and behavioral change at the workplace
436
Safety culture and hazard risk perception of Australian and New Zealand maritime pilots
437
Safety Culture and Resilience in a Petrochemical Industry
438
Safety culture and safety management aboard tankers
439
Safety culture and safety management aboard tankers
440
Safety culture enhancement through the implementation of IAEA guidelines
441
Safety culture enhancement through the implementation of IAEA guidelines
442
Safety culture in GolGohar Mine in Southeast Iran in 2014
443
Safety culture in railway maintenance
444
Safety culture in Swedish air traffic control
445
Safety culture: a survey of the state-of-the-art
446
Safety culture: a survey of the state-of-the-art
447
Safety culture: Analysis of the causal relationships between its key dimensions
448
Safety design for ITER and fusion power reactors
449
Safety design of compressed hydrogen trailers with composite cylinders
450
Safety design of next generation SUI of CANDU stations
451
Safety design of radiation shielding for JT-60SA
452
Safety design of steel beams with time-dependent stability
453
Safety design: Towards a new philosophy
454
Safety determination for the use of bovine milk-derived lactoferrin as a component of an antimicrobial beef carcass spray
455
Safety diagnosis criteria—development and testing
456
Safety diagnosis in industrial work settings: The safety diagnosis questionnaire
457
Safety distance between underground natural gas and water pipeline facilities
458
Safety distances: Definition and values
459
Safety effects of roundabouts in Flanders: Signal type, speed limits and vulnerable road users
460
Safety equipment handbook: a practical guide to pesticide safety requirements: BCPC publications, Berks, 2002, 80pp., price £10, ISBN 1 901396 06 1
461
Safety estimation of structural systems via interval analysis
462
Safety Evaluation and Confidence Intervals When the Number of Observed Events Is Small or Zero, ,
463
Safety evaluation and fluorine concentration of puʹer brick tea and bianxiao brick tea
464
Safety evaluation and nutritional composition of a Fraxinus excelsior seed extract, FraxiPure™
465
Safety Evaluation and Risk Assessment of the Herbicide Roundup and Its Active Ingredient, Glyphosate, for Humans
466
Safety evaluation of 1,4-α-glucan branching enzymes from Bacillus stearothermophilus and Aquifex aeolicus expressed in Bacillus subtilis
467
Safety evaluation of 70 MPa-capacity type III hydrogen pressure vessel considering material degradation of composites due to temperature rise
468
Safety evaluation of a glucanase preparation intended for use in food including a subchronic study in rats and mutagenicity studies
469
Safety evaluation of a hexose oxidase expressed in Hansenula polymorpha
470
Safety evaluation of a high lipid Whole Algalin Flour (WAF) from Chlorella protothecoides
471
Safety evaluation of a high-lipid algal biomass from Chlorella protothecoides
472
Safety evaluation of a lactase enzyme preparation derived from Kluyveromyces lactis
473
Safety evaluation of a lipase enzyme (BD29241 Palmitase) preparation, expressed in Pseudomonas fluorescens, intended for removing palmitic acid from triacylglycerol
474
Safety evaluation of a lipase enzyme preparation, expressed in Pichia pastoris, intended for use in the degumming of edible vegetable oil
475
Safety evaluation of a lipase expressed in aspergillus oryzae
476
Safety evaluation of a medium- and long-chain triacylglycerol oil produced from medium-chain triacylglycerols and edible vegetable oil
477
Safety evaluation of a milk basic protein fraction
478
Safety evaluation of a natural eggshell membrane-derived product
479
Safety evaluation of a natural tomato oleoresin extract derived from food-processing tomatoes
480
Safety evaluation of a novel whitening gel, containing 6% hydrogen peroxide and a commercially available whitening gel containing 18% carbamide peroxide in an exaggerated use clinical study
481
Safety evaluation of a phytase, expressed in Schizosaccharomyces pombe, intended for use in animal feed
482
Safety evaluation of a standardized phytochemical composition extracted from Bacopa monnieri in Sprague–Dawley rats
483
Safety evaluation of a thermolysin enzyme produced from Geobacillus stearothermophilus
484
Safety evaluation of a triterpenoid-rich extract from bamboo shavings
485
Safety evaluation of a xylanase expressed in Bacillus subtilis
486
Safety evaluation of Algal Oil from Schizochytrium sp.
487
Safety Evaluation of Amino Peptidase Enzyme Preparation derived from Aspergillus niger
488
Safety evaluation of amylomaltase from Thermus aquaticus
489
Safety evaluation of an artificial groundwater recharge system for reclaimed water reuse based on bioassays Original Research Article
490
Safety evaluation of an enzymatically-synthesized glycogen (ESG)
491
Safety evaluation of an extract from Salacia oblonga
492
Safety evaluation of an IPP tripeptide-containing milk protein hydrolysate
493
Safety evaluation of an α-amylase enzyme preparation derived from the archaeal order Thermococcales as expressed in Pseudomonas fluorescens biovar I
494
Safety evaluation of an α-cyclodextrin glycosyltranferase preparation
495
Safety Evaluation of Aqueous Extract of Garcinia Kola Seeds in Male Wistar Rats
496
Safety evaluation of arachidonic acid rich Mortierella alpina biomass in albino rats—A subchronic study
497
Safety evaluation of biological drugs: What are toxicology studies in primates telling us?
498
Safety evaluation of certain contaminants in food
499
Safety evaluation of certain food additives
500
Safety evaluation of certain food additives and contaminants: Prepared by the fifty-seventh meeting of the Joint FAO/WHO Expert Committee on Food Additives (JECFA), WHO Food Additives Series 48, WHO, Geneva, 2002, International Programme on Chemical Safet
501
Safety evaluation of certain food additives and contaminants: Prepared by the Fifty-third meeting of the joint FAO/WHO Expert Committee on Food Additives (JECFA). WHO Food Additives Series: 44; WHO, Geneva, 2000, IPCS – International Programme on Chemical
502
Safety evaluation of certain food additives: Prepared by the fifty-first meeting of the joint FAO/WHO Expert Committee on Food Additives (JECFA). WHO Food Additives Series 42; WHO, Geneva, 1999, IPCS-International Programme on Chemical Safety, 490 pages;
503
Safety Evaluation of Certain Food Additives: Prepared by the Fifty-Ninth Meeting of the Joint FAO/WHO Expert Committee on Food Additives (JECFA), WHO Food Additives Series: 50; International Programme on Chemical Safety, IPCS, WHO, Geneva, 2003, vi+425 pa
504
Safety evaluation of certain mycotoxins in food: Prepared by the fifty-sixth meeting of the joint FAO/WHO Expert Committee on Food Additives (JECFA). WHO Food Additives Series: 47; FAO Food and Nutrition Paper: 74; IPCS-International Programme on Chemical
505
Safety evaluation of chicken breast extract containing carnosine and anserine
506
Safety evaluation of chloramine –T on ornamental zebra fish (Danio rerio) using LC50 calculation and organ pathology
507
Safety Evaluation of Crocin (a constituent of saffron) Tablets in Healthy Volunteers
508
Safety evaluation of daidzein in laying hens: Part I. Effects on laying performance, clinical blood parameters, and organs development
509
Safety evaluation of daidzein in laying hens: Part II. Effects on calcium-related metabolism
510
Safety evaluation of DHA-rich Algal Oil from Schizochytrium sp.
511
Safety Evaluation of Dietary Aluminum
512
Safety Evaluation of Doogh, a Traditional Iranian Dairy Product, in Khuzestan, Iran: A Cross-Sectional Study on Microbiological, Chemical and Toxicological Aspects
513
Safety evaluation of Elsholtzia splendens extracts: Assessment of acute toxicity and mutagenicity
514
Safety evaluation of EvesseTM EPC, an apple polyphenol extract rich in flavan-3-ols
515
Safety Evaluation of Ferrous Bisglycinate Chelate
516
Safety evaluation of fibermalt
517
Safety evaluation of formulations containing carboxymethyl derivatives of starch and chitosan in albino rats
518
Safety evaluation of functional ingredients
519
Safety evaluation of gas storage caverns located close to a tectonic fault
520
Safety evaluation of glucose oxidase from Penicillium chrysogenum
521
Safety evaluation of highly-branched cyclic dextrin and a 1,4-α-glucan branching enzyme from Bacillus stearothermophilus
522
Safety evaluation of highway geometric design criteria in horizontal curves at downgrades
523
Safety evaluation of human accidents in coal mine based on ant colony optimization and SVM
524
Safety evaluation of ice-structuring protein (ISP) type III HPLC 12 preparation. Lack of genotoxicity and subchronic toxicity
525
Safety evaluation of Lactobacillus pentosus strain b240
526
Safety evaluation of lipase derived from Rhizopus oryzae: Summary of toxicological data
527
Safety Evaluation of Lipase Produced from Candida rugosa: Summary of Toxicological Data
528
Safety evaluation of lipase produced from Rhizopus oryzae: summary of toxicological data
529
Safety evaluation of longan seed extract: Acute and repeated oral administration
530
Safety Evaluation of Low-Rise Steel Structures under Wind Loads by Nonlinear Database-Assisted Technique
531
Safety Evaluation of Mangifera Indica Bark for Raw Water Purification
532
Safety evaluation of meso-zeaxanthin
533
Safety evaluation of Monascus purpureus red mould rice in albino rats
534
Safety Evaluation of Monophosphoryl Lipid A (MPL): An Immunostimulatory Adjuvant
535
Safety evaluation of Mucor rouxii CFR-G15 biomass containing ω-6 fatty acids in rats
536
Safety Evaluation of Nano Iron Zero Valente Green Synthesized: A Comparative Study
537
Safety evaluation of nano/sub-microsized lignan glycosides from sesame meal
538
Safety Evaluation of Nano-Liposomal Formulation of Amphotericin B (SinaAmpholeish) in Animal Model as a Candidate for Treatment of Cutaneous Leishmaniasis
539
Safety evaluation of nonthermal atmospheric pressure plasma liquid treatment: Single DNA molecule-based method
540
Safety evaluation of Nostoc flagelliforme (nostocales, cyanophyceae) as a potential food
541
Safety evaluation of oleic-rich triglyceride oil produced by a heterotrophic microalgal fermentation process
542
Safety evaluation of oligofructose: 13 Week rat study and in vitro mutagenicity
543
Safety evaluation of pectin-derived acidic oligosaccharides (pAOS): Genotoxicity and sub-chronic studies
544
Safety evaluation of perfluoropolyethers, liquid polymers used in barrier creams and other skin-care products
545
Safety evaluation of phosphodiesterase derived from Leptographium procerum
546
Safety Evaluation of Phosphodiesterase Produced from Penicillium citrinum: Summary of Toxicological Data
547
Safety evaluation of phytosterol esters. Part 1. Assessment of oestrogenicity using a combination of in vivo and in vitro assays
548
Safety Evaluation of Phytosterol Esters. Part 2. Subchronic 90-Day Oral Toxicity Study on Phytosterol Esters–A Novel Functional Food
549
Safety Evaluation of Phytosterol Esters. Part 3. Two-Generation Reproduction Study in Rats with Phytosterol Esters—a Novel Functional Food
550
Safety Evaluation of Phytosterol Esters. Part 4. Faecal Concentrations of Bile Acids and Neutral Sterols in Healthy Normolipidaemic Volunteers Consuming a Controlled Diet either with or without a Phytosterol Ester-enriched Margarine
551
Safety evaluation of phytosterol esters. Part 5. Faecal short-chain fatty acid and microflora content, faecal bacterial enzyme activity and serum female sex hormones in healthy normolipidaemic volunteers consuming a controlled diet either with or without
552
Safety evaluation of phytosterol esters. Part 7. Assessment of mutagenic activity of phytosterols, phytosterol esters and the cholesterol derivative, 4-cholesten-3-one
553
Safety evaluation of phytosterol esters. Part 8. Lack of genotoxicity and subchronic toxicity with phytosterol oxides
554
Safety evaluation of phytosterol-esters. Part 9: Results of a European post-launch monitoring programme
555
Safety evaluation of Phytovagex, a pessary formulation of Nigella sativa, on pregnant rats
556
Safety evaluation of pigment containing Aspergillus carbonarius biomass in albino rats
557
Safety evaluation of polydextrose in infant formula using a suckling piglet model
558
Safety evaluation of polyphenols extracted from hop bracts
559
Safety Evaluation of Primary-Side Bleed-and-Feed Scenarios by an Experimental Loss of Feedwater Event at the IIST Facility
560
Safety evaluation of proanthocyanidin polymer-rich fraction obtained from stem bark of Stryphnodendron adstringens (BARBATIMأO) for use as a pharmacological agent
561
Safety evaluation of proanthocyanidin-rich extract from grape seeds
562
Safety evaluation of Propionibacterium freudenreichii ET-3 culture
563
Safety evaluation of protein of silkworm (Antheraea pernyi) pupae
564
Safety evaluation of saffron stigma (Crocus sativus L.) aqueous extract and crocin in patients with schizophrenia
565
Safety evaluation of shallow tunnel based on elastoplastic-viscoplastic analysis
566
Safety evaluation of short-term exposure to chitooligomers from enzymic preparation
567
Safety evaluation of slender high-strength concrete columns under sustained loads
568
Safety evaluation of small-break LOCA with various locations and sizes for SMART adopting fully passive safety system using MARS code
569
Safety evaluation of some wild plants in the New Nordic Diet
570
Safety evaluation of sources of docosahexaenoic acid and arachidonic acid for use in infant formulas in newborn piglets
571
Safety evaluation of steroidal saponin DT-13 isolated from the tuber of Liriope muscari (Decne.) Baily
572
Safety evaluation of superabsorbent baby diapers
573
Safety evaluation of table liner for vertical roller mill by modified fatigue limit
574
Safety evaluation of tannase enzyme preparation derived from Aspergillus oryzae
575
Safety evaluation of the double mutant 5-enol pyruvylshikimate-3-phosphate synthase (2mEPSPS) from maize that confers tolerance to glyphosate herbicide in transgenic plants
576
Safety evaluation of the inherent and passive safety features of the smart design
577
Safety evaluation of the phosphinothricin acetyltransferase proteins encoded by the pat and bar sequences that confer tolerance to glufosinate-ammonium herbicide in transgenic plants
578
Safety evaluation of the rocker arm of a diesel engine
579
Safety Evaluation of Topical Application of NanoLiposomal Form of Amphotericin B (SinaAmpholeish) on Healthy Volunteers: Phase I Clinical Trial
580
Safety Evaluation of Tricalcium Phosphate/Collagen Nanocomposite Scaffold in Bone Defect in New Zealand White Rabbit Model
581
Safety evaluation of water extracts of Toona sinensis Roemor leaf
582
Safety evaluation of Whole Algalin Protein (WAP) from Chlorella protothecoides
583
Safety evaluation of wild apricot oil
584
Safety evaluation of yeast glutaminase
585
Safety evaluation of zeaxanthin concentrate (OmniXan™): Acute, subchronic toxicity and mutagenicity studies
586
Safety evaluation of α-lipoic acid (ALA)
587
Safety evaluation of β-glucanase derived from trichoderma reesei: Summary of toxicological data
588
Safety evaluation on fluoride content in black tea
589
Safety evaluation on the clinical application of Tenghuangjiangu tablet for osteoarthritis: a hospital registration study
590
Safety evaluation studies on argemone oil through dietary exposure for 90 days in rats
591
Safety evaluation to support First-In-Man investigations I: Kinetic and safety pharmacology studies
592
Safety evaluation to support first-in-man investigations II: Toxicology studies
593
Safety examination of existing concrete structures using the global resistance safety factor concept
594
Safety factor nomograms for homogeneous earth dams less than ten meters high
595
Safety Factor of Pump Vibrations on Ships Based on The Natural Frequency of Pump Vibrations According to ISO 10816-3
596
Safety factor requirements for the offshore industry
597
Safety Factors and Patterns of Bicycle Trauma in a Tertiary Level 1 Trauma Center in Boston, Massachusetts: A Retrospective Review and Survey Study
598
Safety factors considered by industrial contractors in Saudi Arabia
599
Safety factors for bridge falsework by risk management
600
Safety factors for the structural design of glass
601
Safety factors in civil aircraft design requirements
602
Safety factors in the design and use of pressure equipment
603
Safety Factors in Trees
604
Safety formats for nonlinear analysis tested on concrete beams subjected to shear forces and bending moments
605
Safety functions and component classification for the HTR-10 Original Research Article
606
Safety goals for a fusion reactor
607
Safety goals in ‘risk-informed, performance-based’ regulation
608
Safety goals in ‘risk-informed, performance-based’ regulation
609
Safety Guards for Ethereum Smart Contracts
610
Safety guidelines for exercise during pregnancy
611
Safety halls—an evaluation
612
Safety handling characteristics of high-level tritiated water
613
Safety hazard and time to recall: The role of recall strategy, product defect type, and supply chain player in the U.S. toy industry
614
Safety hazard and time to recall: The role of recall strategy, product defect type, and supply chain player in the U.S. toy industry
615
Safety I to Safety II: A Paradigm Shift or More Work as Imagined?; Comment on “False Dawns and New Horizons in Patient Safety Research and Practice”
616
Safety impact of engineering treatments on undivided rural roads
617
Safety implication for an unsaturated zone nuclear waste repository
618
Safety implications of an integrated boiling curve model for water-cooled divertor channels
619
Safety implications of CLiFF liquid metal first walls
620
Safety implications of cultural and cognitive issues in nuclear power plant operation
621
Safety implications of extending some Canadian Motor Vehicle Safety Standards to light trucks and vans
622
Safety implications of providing real-time feedback to distracted drivers
623
Safety improvement and preservation of typical sensory qualities of traditional dry fermented sausages using autochthonous starter cultures
624
Safety improvement issues for mission aborts of future space transportation systems
625
Safety improvement of lithium ion batteries by organo-fluorine compounds
626
Safety improvement of pool type FBR against loss of flow accident
627
Safety in Agricultural Extension and Development in Cross River State
628
Safety in design – Can one industry learn from another?
629
Safety in Engineering: Transactions of 3rd. BBB Symposium on Safety in Engineering, Buenos Aires, August 2000, Academia Nacional de Ingeniería, Editorial Dunken, 2000
630
Safety in Laboratories: Indian Scenario
631
Safety in Marine Operations
632
Safety in numbers: A model of managerial herd behavior
633
Safety in nursing social research
634
Safety in residential buildings-Evacuation from residential buildings without fire escape stairs
635
Safety in shipping: The human element
636
Safety in the design of offshore platforms: Integrated safety versus safety as an add-on characteristic
637
Safety in the Handling of Cryogenic Fluids : Frederick J. Edeskuty and Walter F. Stewart, Plenum Press, New York, 1996, 234 pp.
638
Safety in the histochemistry laboratory
639
Safety Incentives: Do They Reduce Injuries?
640
Safety informing design
641
SAFETY INFRASTRUCTURE FOR COUNTRIES ESTABLISHING THEIR FIRST RESEARCH REACTOR
642
Safety Instrumented System Design: Lessons Learned
643
Safety Instrumented System Design: Lessons Learned
644
Safety Investigation of Liquid-Metal-Cooled Nuclear Systems with Heat Exchanger in the Risers of Simple FlowPath Pool Design
645
Safety issues and approach to meet the safety requirements in the tokamak cooling water system of ITER
646
Safety issues associated with mobilized activation products in selected APEX designs
647
Safety issues in modern applications of robots
648
Safety issues of nuclear production of hydrogen
649
Safety issues of the liquefaction, storage and transportation of liquid hydrogen: An analysis of incidents and HAZIDS
650
Safety issues on laser megajoule facility
651
Safety knowledge of users and non-users of the lap belt on two-point motorized belt systems
652
Safety learning and imagination versus safety bureaucracy in design of the traffic sector
653
Safety level of levofloxacin following repeated oral administration in White Leg Horn layer birds
654
Safety Management Assessment System (SMAS): a process for identifying and evaluating human and organization factors in marine system operations with field test results
655
Safety Management Based on Detection of Possible Rock Bursts by AE Monitoring during Tunnel Excavation
656
Safety Management in the Jordanian Construction Industry
657
Safety Management Practices in the Bhutanese Construction Industry
658
Safety Management Strategy and Practice : R. Pybus, 1996, Butter-worth-Heinemann, ISBN 0 7506 2519 8
659
Safety Management Systems : Alan Waring, Champion&Hall, London, pp 241. ISBN 0-412-71910-X
660
Safety management systems and safety culture in aircraft maintenance organisations
661
Safety managements of the linear IFMIF/EVEDA prototype accelerator
662
Safety margin for HDR brachytherapy boost in locally advanced breast cancer
663
Safety margins confidence estimation for a passive residual heat removal system
664
Safety margins confidence estimation for a passive residual heat removal system
665
Safety margins in establishing challenges to cleaning processes are still a good idea
666
Safety margins of the W7-X plasma vessel for the static case
667
Safety Margins: Lessons from the Low Energy Endotak Trial (LEET)
668
Safety mechanisms in lithium-ion batteries
669
Safety method, Spectrophotometric Determination of Sulfamethaxazole drug in bulk and Pharmaceutical Preparations
670
Safety modeling and simulation of multi-factor coupling heavy-equipment airdrop
671
Safety monitoring of exothermic reactions using time derivatives of temperature sensors
672
Safety monitoring of herbal medicines in Nigeria: worrying state of pharmacovigilance system based on WHO core pharmacovigilance indicators
673
Safety monitoring, capital structure, and “financial responsibility”
674
Safety Motivation and Work Pressure as Predictors of Occupational Accidents in the Petrochemical Industry
675
Safety networks: fishery barometers and the outsourcing of judgement at the early Meteorological Department
676
Safety Nursing Measures for Patients Undergoing Upper Gastrointestinal Endoscopy
677
Safety objectives for next generation reactors: Proving their achievement Original Research Article
678
Safety of “Bridging” With Eptifibatide for Patients With Coronary Stents Before Cardiac and Non-Cardiac Surgery
679
Safety of <7500 RE (<25000 IU) vitamin A daily in adults with retinitis pigmentosa
680
Safety of 65 °C intravenous fluid for the treatment of hypothermia
681
Safety of a Filtrate of Fermented Garambullo Fruit: Biotransformation and Toxicity Studies
682
Safety of a New Intranasal Vaccine Against Equine Influenza: A Study of the Stability of the Ts Ca Phenotype of the Reassortant Strain in a Natural Host
683
Safety of a Trivalent Inactivated Influenza Vaccine in Health Care Workers in Kurdistan Province, Western Iran; A Longitudinal Follow-up Study
684
Safety of abciximab during percutaneous coronary intervention in patients with chronic renal insufficiency
685
Safety of abciximab in patients with chronic renal insufficiency who are undergoing percutaneous coronary interventions
686
Safety of abstract interpretations for free, via logical relations and Galois connections
687
Safety of Adenosine for Acute Pulmonary Vasoreactivity Testing in Pulmonary Hypertension
688
Safety of adjuvant aromatase inhibitor therapy
689
Safety of Aggressive Lipid Management Review Article
690
Safety of antihypertensive therapy a series of interactive panels
691
Safety of Anti-TNF-α Therapy in Patients With Psoriasis and Concomitant Hepatitis C Virus Infection
692
Safety of aprotinin (again)
693
Safety of Aqueous Extract of Tinospora cordifolia (Tc) in Healthy Volunteers: A Double Blind
694
Safety of aspartame
695
Safety of atorvastatin derived from analysis of 44 completed trials in 9,416 patients
696
SAFETY OF BLOOD an‎d PLASMA DERIVATIVES: PATHOGEN REDUCING TECHNOLOGIES
697
Safety of botanical ingredients in personal care products/cosmetics
698
Safety of Brucella abortus RB51 vaccination of adult cows: Bacteriological evaluation of milk
699
Safety of Brucella abortus RB51 vaccination of adult cows: Bacteriological evaluation of milk
700
Safety of Brucella abortus RB51 vaccination of adult cows: Bacteriological evaluation of milk
701
Safety of Brucella abortus RB51 vaccination of adult cows: Bacteriological evaluation of milk
702
Safety of Brucella abortus RB51 vaccination of adult cows: Bacteriological evaluation of milk
703
Safety of Brucella abortus RB51 vaccination of adult cows: Bacteriological evaluation of milk
704
Safety of calcium antagonists
705
Safety of Calcium Antagonists: Dissecting the Evidence
706
Safety of Cardiac Catheterization in Patients With End-Stage Liver Disease Awaiting Liver Transplantation
707
Safety of Catheter-Based Intramyocardial Autologous Bone Marrow Cells Implantation for Therapeutic Angiogenesis
708
Safety of cefepime: A new extended-spectrum parenteral cephalosporin
709
Safety of combined oral contraceptive pills
710
Safety of compressed hydrogen fuel tanks: Leakage from stationary vehicles
711
Safety of Computed Tomography in Patients With Cardiac Rhythm Management Devices: Assessment of the U.S. Food and Drug Administration Advisory in Clinical Practice
712
Safety of concomitant therapy with eptifibatide and enoxaparin in patients undergoing percutaneous coronary intervention: Results of the coronary revascularization using integrilin and single bolus enoxaparin study
713
Safety of Construction in Projects in Jordan
714
Safety of Continuous Anticoagulation With Dabigatran During Implantation of Cardiac Rhythm Devices
715
Safety of Contrast Administration for Endocardial Enhancement During Stress Echocardiography Compared With Noncontrast Stress
716
Safety of Contrast in Stress Echocardiography in Stable Patients and in Patients With Suspected Acute Coronary Syndrome but Negative 12-Hour Troponin
717
Safety of controlled-onset extended-release verapamil in middle-aged and older patients with hypertension and coronary artery disease
718
Safety of coronary angioplasty to chronic total occlusions
719
Safety of coronary stenting with eptifibatide and ultra-low-dose heparin
720
Safety of Dabigatran Versus Warfarin for Periprocedural Anticoagulation in Patients Undergoing Ablation for Atrial Fibrillation
721
Safety of dapsone as Pneumocystis carinii pneumonia prophylaxis in human immunodeficiency virus-infected patients with allergy to trimethoprim/sulfamethoxazole
722
Safety of Deep Sedation with General Anesthesia for Minor Invasive Procedures in Pediatric Hematology/Oncology Patients
723
Safety of deferring angioplasty in patients with normal coronary flow velocity reserve
724
Safety of Dental Extractions During Uninterrupted Single or Dual Antiplatelet Treatment
725
Safety of Diagnostic Balloon Occlusion in Normal Coronary Arteries
726
Safety of diagnostic coronary angiogram by radial approach in patients on chronic anticoagulation therapy with coumarin derivatives
727
Safety of Diagnostic Coronary Angiography During Uninterrupted Therapeutic Warfarin Treatment
728
Safety of dietary conjugated α-linolenic acid (CLNA) in a neonatal pig model
729
Safety of Digestive Endoscopy following Acute Coronary Syndrome: A Systematic Review
730
Safety of dipyridamole testing in patients with cerebrovascular disease
731
Safety of Dobutamine Contrast Stress Echocardiography
732
Safety of dobutamine stress real-time myocardial contrast echocardiography Original Research Article
733
Safety of Dronedarone in Routine Clinical Care
734
Safety of Drug-Eluting Stents in Patients With Left Ventricular Dysfunction Undergoing Percutaneous Coronary Intervention
735
Safety of Drug-Eluting Stents in the Coronary Artery in ST-Elevation Myocardial Infarction at a Single High-Volume Medical Center
736
Safety of drug-eluting stents: demystifying network meta-analysis
737
Safety of dynamic positioning operations on mobile offshore drilling units
738
Safety of dynamic positioning operations on mobile offshore drilling units
739
Safety of early intravenous dipyridamole technetium 99m sestamibi SPECT myocardial perfusion imaging after uncomplicated first myocardial infarction
740
SAFETY OF EARLY ORAL FEEDING AFTER TRANSHIATAL ESOPHAGECTOMY: PRELIMINARY REPORT OF A PROSPECTIVE TRIAL
741
SAFETY OF EARLY VERSUS DELAYED ENTERAL FEEDING FOLLOWING ILEOSTOMY CLOSURE: RANDOMIZED CONTROLLED TRIAL
742
Safety of elective—including “high risk”—percutaneous coronary interventions without on-site cardiac surgery
743
Safety of electronic circuits integrated into personal protective equipment (PPE)
744
Safety of enoxaparin versus unfractioned heparin in patients undergoing percutaneous coronary intervention using drug eluting stents: A pilot study
745
Safety of erythritol in the diet
746
Safety of Exercise Stress Testing in Patients With Abnormal Concentrations of Serum Potassium
747
Safety of Expedited Anticoagulation in Patients Undergoing Transesophageal Echocardiographic-guided Cardioversion
748
Safety of fast neutron reactor power units under operation and design in Russia Original Research Article
749
Safety of femoral closure devices after percutaneous coronary interventions in the era of glycoprotein IIb/IIIa platelet blockade
750
Safety of first-trimester exposure to topical tretinoin: prospective cohort study
751
Safety of fusion magnets: Model experiments to high current arcs at ITER busbars and feeder lines
752
Safety of fusion magnets: Pressure impact on arcing in model experiments to high-current arcs propagating along the busbars of large fusion magnet coils
753
Safety of Genetically Engineered Foods. Approaches to Assessing Unintended Health Effects
754
Safety of Genetically Engineered Foods: Approaches to Assessing Unintended Health Effects, Institute of Medicine and National Research Council of the National Academies. The National Academies Press, Washington, USA (2004), ISBN: 0-309-09209-4
755
Safety of glycoprotein IIb-IIIa inhibitors: A heart surgeon’s perspective
756
Safety of gold in stapes surgery
757
Safety of HealthcareWorkers During the Airway Management in Adult and Pediatric Patients with COVID-19
758
Safety of heart rate–lowering calcium antagonists:Lessons from controlled trials, ,
759
Safety of herbal medicine in treatment of weight loss
760
Safety of high doses of Propionibacterium freudenreichii ET-3 culture in healthy adult subjects
761
Safety of High-Dose Atorvastatin Therapy
762
Safety of hydroxychloroquine in pregnant patients with connective tissue diseases. Review of the literature
763
Safety of Hypericum extract in mildly to moderately depressed outpatients: A review based on data from three randomized, placebo-controlled trials
764
Safety of Imaging Exploding Bullets With Ultrasound, ,
765
Safety of immunization and adverse events following vaccination against hepatitis B
766
Safety of implantation of a cardioverter-defibrillator without general anesthesia in an electrophysiology laboratory
767
Safety of Improved Milbond-TX® when fed in broiler diets at greater than recommended levels
768
Safety of Inactivated Influenza Vaccine in Patients with Egg Allergy in Kurdistan Province, Iran
769
Safety of influenza vaccination during pregnancy
770
Safety of influenza vaccination during pregnancy
771
Safety of influenza vaccines in children
772
Safety of injectable opioid maintenance treatment for heroin dependence
773
Safety of Inoue balloon mitral commissurotomy in patients with left atrial appendage thrombi
774
Safety of insulin glargine
775
Safety of insulin tolerance test for the assessment of growth hormone deficiency in children
776
Safety of intra-amniotic digoxin administration before late second-trimester abortion by dilation and evacuation,
777
Safety of intracoronary Doppler flow measurement
778
Safety of Intracoronary Ultrasound Imaging in Patients With Acute Myocardial Infarction
779
Safety of intramedullary autologous peripheral nerve grafts for post-rehabilitated complete motor spinal cord injuries: a phase I study.
780
Safety of intravenous immunoglobulin (IVIG) therapy
781
Safety of Intravenous Thrombolysis for Stroke in a Patient With Multiple Intracranial Neoplasm
782
Safety of intravenous use of ketorolac in infants following cardiothoracic surgery
783
Safety of Intravitreal Injection of Stivant, a Biosimilar to Bevacizumab, in Rabbit Eyes
784
Safety of Intravitreal Zoledronic Acid, an Anti-angiogenic Bisphosphonate, in a Rat Model
785
Safety of irbesartan in the treatment of mild to moderate systemic hypertension
786
Safety of irradiated foods (2nd edition): J. F. Diehl. Marcel Dekker Inc., 1995. ISBN 0 82479 344 7. 464 pp. $175
787
Safety of irradiated foods (2nd edition): J. F. Diehl. Marcel Dekker Inc., 1995. ISBN 0 82479 344 7. 464 pp. $175
788
Safety of Ivabradine in Patients With Coronary Artery Disease and Left Ventricular Systolic Dysfunction (from the BEAUTIFUL Holter Substudy)
789
Safety of Ketoprofen in Cow calves following repeated intravenous administration
790
Safety of labor epidural anesthesia for women with severe hypertensive disease, , ,
791
Safety of lacosamide in children with refractory partial epilepsy
792
Safety of left innominate vein division during aortic arch surgery
793
Safety of left ventriculography in aortic stenosis
794
Safety of lithium batteries in transportation
795
Safety of long railway tunnels
796
Safety of long railway tunnels
797
Safety of Lovastatin/Extended Release Niacin Compared With Lovastatin Alone, Atorvastatin Alone, Pravastatin Alone, and Simvastatin Alone (from the United States Food and Drug Administration Adverse Event Reporting System)
798
Safety of low hematocrits during cardiopulmonary bypass
799
Safety of low-density lipoprotein cholesterol reduction with atorvastatin versus simvastatin in a coronary heart disease population (the TARGET TANGIBLE Trial)
800
Safety of Lower Activated Clotting Times During Atrial Fibrillation Ablation Using Open Irrigated Tip Catheters and a Single Transseptal Puncture
801
Safety of lumbar drains in thoracic aortic operations performed with extracorporeal circulation
802
Safety of Magnetic Resonance Imaging One to Three Days After Bare Metal and Drug-Eluting Stent Implantation
803
Safety of maritime transportation
804
Safety of medically supervised exercise in a cardiac rehabilitation center
805
Safety of Methotrexate in Chronic Urticaria Unresponsive to Omalizumab
806
Safety of metronidazole in pregnancy: A meta-analysis
807
Safety of Microorganisms Intended for Pest and Plant Disease Control: A Framework for Scientific Evaluation
808
Safety of Minimally Invasive Mitral Valve Surgery Without Aortic Cross-Clamp
809
Safety of minocycline for acne
810
Safety of modern oral contraceptives
811
Safety of Moxifloxacin following repeated intramuscular administration in Wistar rats
812
Safety of Naloxone in Opioid-Naive Methadone Intoxicated Patients; a Case Series Study
813
Safety of nicotine in smokers with hypertension
814
Safety of oral immunisation with recombinant urease in patients with Helicobacter pylori infection
815
Safety of oral itraconazole in the treatment of seborrheic dermatitis
816
Safety of oral propafenone in the conversion of recent onset atrial fibrillation to sinus rhythm:: A prospective parallel placebo-controlled multicentre study
817
Safety of Oral Propafenone in the Treatment of Arrhythmias in Infants and Children (European Retrospective Multicenter Study)
818
Safety of outpatient dental anaesthesia for children
819
Safety of parenteral dexamethasone vs. oral prednisolone in the treatment of pemphigus vulgaris
820
Safety of passing longer combination vehicles on two-lane highways
821
Safety of patent ductus arteriosus closure in premature infants without tube thoracostomy
822
Safety of patient meals in 2 hospitals in Alexandria, Egypt before and after training of food handlers
823
Safety of Percutaneous Transfemoral Coronary and Peripheral Procedures Via Aortofemoral Synthetic Vascular Grafts
824
Safety of performing dobutamine stress echocardiography in patients with abdominal aortic aneurysm ≥4 cm in diameter
825
Safety of perioperative statin use in high-risk patients undergoing major vascular surgery
826
Safety of pleurodesis with talc poudrage in malignant pleural effusion: a prospective cohort study
827
Safety of power transmission line structures under wind and ice storms
828
Safety of Prestressed Concrete Bridges to Fatigue: Application to Serviceability Limit State of Decompression
829
Safety of primary percutaneous coronary intervention with and without (selective) thrombus aspiration
830
Safety of probiotics in patients receiving enteral or parenteral nutrition: a systematic review of trials and case reports
831
Safety of prolonging peripheral cannula and IV tubing use from 72 hours to 96 hours, ,
832
Safety of psychotropic medications in liver disease
833
Safety of purified decolorized (low anthraquinone) whole leaf Aloe vera (L) Burm. f. juice in a 3-month drinking water toxicity study in F344 rats
834
Safety of PVAP and PVAP-T including a 90-day dietary toxicity study in rats and genotoxicity tests with polyvinyl acetate phthalate (PVAP)
835
Safety of Radiofrequency Ablation of Thoracic T2 and T3 Sympathectomy in Palmar Hyperhidrosis: A Case Report
836
Safety of Raloxifene in Hemodialysis Patients
837
Safety of raltitrexed
838
Safety of raltitrexed
839
Safety of raw meat and shellfish in Vietnam: An analysis of Escherichia coli isolations for antibiotic resistance and virulence genes
840
Safety of recommended doses of paracetamol
841
Safety of Regadenoson in Patients with End-Stage Renal Disease
842
Safety of Reloading Prasugrel in Addition to Clopidogrel Loading in Patients With Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention
843
Safety of remote aortic valve replacement after prior coronary artery bypass grafting
844
Safety of repeat aprotinin administration for LVAD recipients undergoing cardiac transplantation
845
Safety of RNA-Dependent RNA Polymerase Inhibitors, Molnupiravir and VV116, for Oral Treatment of COVID-19: A Meta-Analysis
846
Safety of rosuvastatin
847
Safety of rTMS to non-motor cortical areas in healthy participants and patients
848
Safety of Same-Day Discharge After Percutaneous Coronary Intervention: What Is the Level of Evidence?
849
Safety of same-day–discharge radial percutaneous coronary intervention: a retrospective study
850
Safety of Selective Serotonin Reuptake Inhibitor in Adults Undergoing Coronary Artery Bypass Grafting
851
Safety of shellfish and epidemiological pattern of enterically transmitted diseases in Italy
852
Safety of short-term cyclosporin in atopic dermatitis
853
Safety of Short-Term Use of Dabigatran or Rivaroxaban for Direct-Current Cardioversion in Patients With Atrial Fibrillation and Atrial Flutter
854
Safety of sildenafil citrate in the management of hypertensive disorders of pregnancy
855
SAFETY OF SINGLE LAYER CONTINUOUS EXTRA MUCOSAL GUT ANASTOMOSIS IN EMERGENCY
856
Safety of Sirolimus-Eluting Stenting and Its Effect on Restenosis in Patients With Unstable Angina Pectoris (a SIRIUS Substudy)
857
Safety of Skeletal Traction through the Distal Femur, Proximal Tibia, and Calcaneus
858
Safety of Slow Pathway Ablation in Patients With Atrioventricular Node Reentrant Tachycardia and a Long Fast Pathway Effective Refractory Period
859
Safety of SodiumGlucose CoTransporter 2 Inhibitors during Ramadan Fasting: Evidence, Perceptions and Guidelines
860
Safety of St Johnʹs wort (Hypericum perforatum)
861
Safety of St Johnʹs wort (Hypericum perforatum)
862
Safety of St Johnʹs wort (Hypericum perforatum)
863
Safety of Stress Echocardiography (from the International Stress Echo Complication Registry)
864
Safety of Stress Echocardiography: The Advantages of Transesophageal Atrial Pacing
865
Safety of stress testing in patients with hypertrophic cardiomyopathy
866
Safety of subxyphoid pericardial access using a blunt-tip needle
867
Safety of succinylcholine in myasthenia gravis
868
Safety of surfaces and equipment for children in playgrounds
869
Safety of surgical personnel: a global concern
870
Safety of Surgical Tracheostomy during Extracorporeal Membrane Oxygenation
871
Safety of tamoxifen
872
Safety of Targeted Perioperative Mupirocin Treatment for Preventing Infections After Cardiac Surgery
873
Safety of the blood supply: role of pathogen reduction
874
Safety of the Excimer Laser in LASIK and PRK for Patients with Implantable Cardiac Devices: Our Clinical Experience in the Past Two Decades
875
Safety of the magnetic field generated by a neuronal magnetic stimulator: evaluation of possible mutagenic effects
876
Safety of the RTS,S/AS02D candidate malaria vaccine in infants living in a highly endemic area of Mozambique: a double blind randomised controlled phase I/IIb trial
877
Safety of the underground disposal of carbon dioxide
878
Safety of the weight-adjusted dosing regimen of tenecteplase in the ASSENT-Trial
879
Safety of Thoracic Aortic Surgery in the Present Era
880
Safety of thrombolytic agents in acute ischemic stroke: Analysis of randomized controlled trials
881
Safety of tibolone in the treatment of vasomotor symptoms in breast cancer patients—Design and baseline data ‘LIBERATE’ trial
882
Safety of topical dinitrochlorobenzene
883
Safety of Transvenous Cardiac Resynchronization System Implantation in Patients With Chronic Heart Failure: Combined Results of Over 2,000 Patients From a Multicenter Study Program Original Research Article
884
Safety of trivalent chromium complexes: No evidence for DNA damage in human HaCaT keratinocytes
885
Safety of tumour necrosis factor and interleukin-1 blocking agents in rheumatic diseases
886
SAFETY OF ULTRASONIC DISSECTION VERSUS CONVENTIONAL ELECTROCAUTERY DISSECTION DURING LAPROSCOPIC CHOLECYSTECTOMY IN TERMS OF GALL BLADDER PERFORATION
887
Safety of Ultrasound Contrast Agents in Patients With Known or Suspected Cardiac Shunts
888
Safety of Ultrasound Contrast Agents in Stress Echocardiography
889
Safety of umbilical cord blood-derived mesenchymal stem cells (MSCs) following 5-azaserine induction and inhibition of human cardiac myocyte apoptosis by MSCs
890
Safety of Vaginal Misoprostol for the Termination of Second Trimester Miscarriage in Women with Previous Uterine Scar in Iraq
891
Safety of vegetables and the use of pesticides by farmers in China: Evidence from Zhejiang province
892
Safety oriented analysis of cold helium–air mixture formation and stratification Original Research Article
893
Safety Outcomes of Intrastromal Injection of Sodium Hypochlorite in the Normal Rabbit Cornea
894
Safety Performance in Ammonia Plants: Survey VI
895
Safety Performance in Ammonia Plants: Survey VI
896
Safety Performance of Subcontractors in the Palestinian Construction Industry
897
Safety pictograms: are they getting the message across?
898
Safety Planning Intervention: A Brief Intervention to Mitigate Suicide Risk Original Research Article
899
Safety practices and depression among farm residents
900
Safety Predictors in Performance of Activities of Daily Living in Patients with Parkinson’s Disease
901
Safety preserving control synthesis for sampled data systems
902
Safety Procedure for Biosafety and Controlling a Communicable Disease: Streptococcus Suis
903
Safety product evaluation: Six years of experience
904
Safety profile and complications of autologous limbal conjunctival transplantation for primary pterygium
905
Safety profile and gender specific differences of a methanol extract of Eriosema laurentii (Leguminosae) in acute and subchronic (28 days) oral toxicity studies in Wistar rats
906
Safety profile assessment and efficacy of chemically characterized Cinnamomum glaucescens essential oil against storage fungi, insect, aflatoxin secretion and as antioxidant
907
Safety profile of a food dextrin: Acute oral, 90-day rat feeding and mutagenicity studies
908
Safety profile of atorvastatin-treated patients with low LDL-cholesterol levels
909
Safety profile of bupropion for chronic obstructive pulmonary disease
910
Safety profile of bupropion for chronic obstructive pulmonary disease
911
Safety profile of bupropion for chronic obstructive pulmonary disease
912
Safety profile of bupropion for chronic obstructive pulmonary disease
913
Safety profile of conjugated linoleic acid in a 12-month trial in obese humans
914
Safety profile of frequent short courses of oral glucocorticoids in acute pediatric asthma: Impact on bone metabolism, bone density, and adrenal function
915
Safety Profile of Levonorgestrel: A Disproportionality Analysis of Food and Drug Administration Adverse Event Reporting System (Faers) Database
916
Safety Profile of Levonorgestrel: A Disproportionality Analysis of Food and Drug Administration Adverse Event Reporting System (FAERS) Database
917
Safety Profile of Liver FibroScan in Patients with Cardiac Pacemakers or Implantable Cardioverter-Defibrillators
918
Safety profile of low-dose aspirin
919
Safety profile of parenteral ketamine and lignocaine infiltration in pediatric operations
920
Safety profile of perindopril
921
Safety profile of RNAi nanomedicines
922
Safety Profile of Subjects Treated to Very Low Low-Density Lipoprotein Cholesterol Levels (<30 mg/dl) With Rosuvastatin 20 mg Daily (from JUPITER)
923
Safety profile of transdermal testosterone therapy in women
924
Safety Profile of Using Ciprofloxacin in Paediatrics: A Systematic Review and Meta-Analysis
925
Safety profiles of leading nonsteroidal anti-inflammatory drugs
926
Safety Program Guidelines for Public School Facility Construction and Operations
927
Safety Property Verification Using Sequential SAT and Bounded Model Checking
928
Safety Recommendations — The engine that drives change
929
Safety requirements for the design of large containers for decommissioning waste
930
Safety risk analysis based on a geotechnical instrumentation data warehouse in metro tunnel project
931
Safety risk assessment and management—the ESA approach
932
Safety Risk Assessment in Educational Environments: A Case Study in Qom University of Medical Sciences
933
Safety Risk Assessment in Medical and Paramedical Education Laboratories
934
Safety Risk Assessment in the Tile Industry with a New Approach
935
Safety Risk Assessment; Using Fuzzy Failure Mode and Effect Analysis and Fault Tree Analysis
936
Safety risk identification system for metro construction on the basis of construction drawings
937
Safety Risk Management in Production Process: A case study in the automotive supplier industry
938
Safety Risk Management of Automaker Industries Using Combination of Fuzzy FMEA and Vikor (Case Study: Pre-Paint Hall of Iran-Khodro Company)
939
Safety rules and regulations on mine sites – The problem and a solution
940
Safety rules: procedural freedom or action constraint?
941
Safety scenario and integrated thermofluid test
942
Safety Signs Perception and Adoption with the ISO and ANSI Standards
943
Safety standards for human exposure to radio frequency radiation and their biological rationale
944
Safety Status of Schools in Shiraz and its Related Factors
945
Safety stocks in multi-stage inventory systems under different service measures
946
SAFETY STRATEGY ALLOCATION SIMULATOR FOR ACCIDENT REDUCTION AND COST SAVINGS IN SAFETY MANAGEMENT SYSTEM
947
Safety strategy for the first deployment of a hydrogen-based green public building in France
948
Safety studies conducted on a proprietary high-purity aloe vera inner leaf fillet preparation, Qmatrix®
949
Safety studies conducted on high-purity trans-resveratrol in experimental animals
950
Safety studies of a hydrogen refuelling station: Determination of the occurrence frequency of the accidental scenarios
951
Safety studies of a novel starch, pullulan: Chronic toxicity in rats and bacterial mutagenicity
952
Safety studies of l-alanyl-l-glutamine (l-AG)
953
Safety studies of LP20 powder produced from heat-killed Lactobacillus plantarum L-137
954
Safety studies of pseudo-ceramide SLE66. Part 2: Metabolism, cytotoxicity and genotoxicity
955
Safety studies of pseudo-ceramide SLE66. Part 3: Effects on embryo/fetal development in rats
956
Safety studies of pseudo-ceramide SLE66: Acute and short-term toxicity
957
Safety studies on epigallocatechin gallate (EGCG) preparations. Part 1: Genotoxicity
958
Safety studies on epigallocatechin gallate (EGCG) preparations. Part 2: Dermal, acute and short-term toxicity studies
959
Safety studies on epigallocatechin gallate (EGCG) preparations. Part 3: Teratogenicity and reproductive toxicity studies in rats
960
Safety studies on high-pressure hydrogen vehicle refuelling stations: Releases into a simulated high-pressure dispensing area
961
Safety studies on Korean fusion DEMO plant using integrated safety assessment methodology
962
Safety studies on products from whole coffee fruit
963
Safety studies related to the spent fuel storage of the Romanian VVR-S reactor
964
Safety studies: Review of loss of plasma control transients in ITER with AINA 3.0 code
965
Safety study of a hydrogen leak in a fuel cell vehicle using computational fluid dynamics
966
Safety study of high-frequency transcranial magnetic stimulation in patients with chronic stroke
967
Safety study of the coupling of a VHTR with a hydrogen production plant
968
Safety system consideration of a supercritical-water cooled fast reactor with simplified PSA
969
Safety systems for the ESES 2002 wind pump
970
Safety target of very large floating structure used as a floating airport
971
Safety teams: Government and business organizations want them and use them, but are they legal?
972
Safety testing of domestic refrigerators using flammable refrigerants
973
Safety testing of GM-rice expressing PHA-E lectin using a new animal test design
974
Safety testing of lithium ion batteries for navy devices
975
Safety testing of tannase from Aspergillus oryzae
976
Safety Testing of Tebufenozide, a New Molt-Inducing Insecticide, for Effects on Nontarget Forest Soil Invertebrates
977
Safety values and safe practices among college students
978
Safety valves for photosynthesis
979
Safety verification for the ECCS driven by the electrically 4 trains during LBLOCA reflood phase using ATLAS
980
Safety Verification of Rate-Monotonic Least-Splitting Real-Time Scheduler on Multiprocessor System
981
Safety Verification of Semi-Algebraic Dynamical Systems via Inductive Invariant
982
Safety warnings and first aid instructions on consumer and pharmaceutical products in Nigeria: has there been an improvement?
983
Safety with access scaffolds: Development of a prototype decision aid based on accident analysis
984
Safety Zone Problem
985
Safety, acceptability, and feasibility of a single-visit approach to cervical-cancer prevention in rural Thailand: a demonstration project
986
Safety, Acceptance, and Hesitancy of COVID-19 Vaccines Among High-risk Sub-populations: A Narrative Review
987
Safety, domain independence and generalized quantification
988
Safety, domain independence and translation of complex value database queries
989
Safety, economic incentives and insurance in the Norwegian petroleum industry
990
Safety, economic incentives and insurance in the Norwegian petroleum industry
991
Safety, effectiveness and costs of different models of organising care for critically ill patients: Literature review
992
Safety, effectiveness and economic aspects of maggot debridement therapy for wound healing
993
Safety, effectiveness and economic evaluation of intra-operative radiation therapy: a systematic review
994
Safety, Effectiveness, and Outcomes of Cardiac Catheterization in Nonagenarians
995
Safety, effectiveness, and outcomes of concomitant use of highly active antiretroviral therapy with drugs for tuberculosis in resource-poor settings
996
Safety, efficacy, and acceptability of medical abortion in China, Cuba, and India: A comparative trial of mifepristone-misoprostol versus surgical abortion, , ,
997
Safety, efficacy, and biomarker findings of PBT2 in targeting Aβ as a modifying therapy for Alzheimerʹs disease: a phase IIa, double-blind, randomised, placebo-controlled trial
998
Safety, efficacy, and pharmacokinetics/pharmacodynamics of daclizumab (anti-CD25) in patients with adult T-cell leukemia/lymphoma
999
Safety, Efficacy, and Tolerability of Sofosbuvir and Ribavirin in Management of Recurrent Hepatitis C Virus Genotype 4 After Living Donor Liver Transplant in Egypt: What Have We Learned so far?
1000
Safety, Efficacy, Predictability and Stability Indices of Photorefractive Keratectomy for Correction of Myopic Astigmatism with Plano-Scan and Tissue-Saving Algorithms
بازگشت